Microfluidic Assaying of Circulating Tumor Cells and Its Application in Risk Stratification of Urothelial Bladder Cancer.

导出 LinkOut

翻译打印收藏纠错

作者： Guanghou,Fu ^[1] ; Kok Suen,Cheng ^[2] ; Anqi,Chen ^[3] ; Zhijie,Xu ^[3] ; Xiaoyi,Chen ^[1] ; Junjie,Tian ^[1] ; Congcong,Xu ^[1] ; Yukun,Sun ^[1] ; Kuang Hong,Neoh ^[3] ; Yun,Dai ^[3] ; Ray P S,Han ^[1] ; Baiye,Jin ^[2]

作者单位： Department of Urology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. ^[1] Jiangzhong Cancer Research Center, Jiangxi University of Traditional Chinese Medicine, Nanchang, China. ^[2] Department of Material Science and Engineering, College of Engineering, Peking University, Beijing, China. ^[3]

关键词 biomarker bladder cancer circulating tumor cells microfluidics risk stratification

DOI 10.3389/fonc.2021.701298

PMID 34178700

发布时间 2023-11-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in oncology

2021年11卷

701298页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Microfluidic Assaying of Circulating Tumor Cells and Its Application in Risk Stratification of Urothelial Bladder Cancer.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Microfluidic Assaying of Circulating Tumor Cells and Its Application in Risk Stratification of Urothelial Bladder Cancer.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除